Veracyte (VCYT) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Veracyte, Inc (VCYT) PT Raised to $55 at Needham & Company
July 30, 2021 6:28 AM EDTNeedham & Company analyst Mike Matson raised the price target on Veracyte, Inc (NASDAQ: VCYT) to $55.00 (from $54.00) while maintaining a Buy rating.
The analyst commented, "VCYT's 2Q21 revenue and EPS beat consensus. Organic revenue growth improved to 77% in 2Q21 from 5.7% in 1Q21 as... More
